Vimarsana
Biggest News Aggregation in the World

Page 20 - Gresham Technologies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Gresham Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Gresham Technologies Today - Breaking & Trending Today

Investegate | Company News | Corporate, London Stock Exchange, Regulatory News Headlines Gresham Technologies sees higher adjusted earnings on increased recurring revenue - Vimarsana News

Investegate | Company News | Corporate, London Stock Exchange, Regulatory News Headlines Gresham Technologies sees higher adjusted earnings on increased recurring revenue

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional bod...

UK TRADING UPDATE SUMMARY: Polarean And Amryt Get US FDA Boost - Vimarsana News

UK TRADING UPDATE SUMMARY: Polarean And Amryt Get US FDA Boost

UK TRADING UPDATE SUMMARY: Polarean And Amryt Get US FDA Boost Wed, 23rd Dec 2020 19:50 (Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Polarean Imaging PLC - medical imaging products developer - Says US Food & Drug Administration approves company's new drug application. "FDA acceptance for the filing of Polarean's NDA represents another important step forward for the Company's platform. If approved, Polarean's drug-device technology could provide a new diagnostic option for patients with pu...

Source: lse.co.uk